Amineptine Stats & Data
ONNOFKFOZAJDHT-UHFFFAOYSA-NPharmacology
DrugBankDescription
The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Mechanism of Action
Amineptine selectively inhibits the reuptake of dopamine and to a lesser extent norepinephrine, thus exerting a powerful and fast-acting antidepressant effect.
Pharmacodynamics
Amineptine is an atypical tricyclic antidepressant.
Indication
For the treatment of depression.
Half-life
48 minutes for the parent drug and 2.5 hours for the metabolites.
Toxicity
PubChemLiver injury risk
High concern (frequent serious cases reported)
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Experience Report Analysis
ErowidDemographics
Gender Distribution
Too few reports for a chart: gender is known from 1 report, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Male 1 of 1
Reports Over Time
Real-World Dose Distribution
ErowidFrom 5 of 5 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.